Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Stevanato Group S.p.A. (STVN : NYSE)

• Company Description    Stevanato Group S.p.A. is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group S.p.A. is based in PIOMBINO DESE, Italy. Number of Employees: 5,521

• Price / Volume Information    Yesterday's Closing Price: $24.10 Daily Weekly Monthly 20 Day Moving Average: 257,993 shares Shares Outstanding: 302.84 (millions) Market Capitalization: $7,298.50 (millions) Beta: 0.56 52 Week High: $28.00 52 Week Low: $17.49 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.05% -1.60% 12 Week 6.54% 2.13% Year To Date 10.60% -3.32%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL PIOMBINO DESE (PD) VIA MOLINELLA 17 - PADUA,L6 35017 ITA ph: 39049931811 fax: - lisa.miles@stevanatogroup.com http://www.stevanatogroup.com

• General Corporate Information    Officers Franco Stevanato - Chief Executive Officer and Chairman Ugo Gay - Chief Operating Officer Marco Dal Lago - Chief Financial Officer Alvise Spinazzi - Director Fabrizio Bonanni - Director Peer Information Stevanato Group S.p.A. (GSAC) Stevanato Group S.p.A. (CASI) Stevanato Group S.p.A. (ALCD.) Stevanato Group S.p.A. (OMNN) Stevanato Group S.p.A. (CGPI.) Stevanato Group S.p.A. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: T9224W109 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/05/26 Share - Related Items Shares Outstanding: 302.84 Most Recent Split Date: (:1) Beta: 0.56 Market Capitalization: $7,298.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.20 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.58 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 17.57% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/05/26

• Fundamental Ratios P/E Current FY Estimate: 41.79 Trailing 12 Months: 40.85 PEG Ratio: 2.38 Price Ratios Price/Book: 4.34 Price/Cash Flow: 31.92 Price / Sales: 5.64 EPS Growth vs. Year Ago Period: 23.08% vs. Previous Quarter: 33.33% Sales Growth vs. Year Ago Period: 16.04% vs. Previous Quarter: 11.56% ROE 09/30/25 - 10.52 06/30/25 - 10.34 03/31/25 - 10.00 ROA 09/30/25 - 6.32 06/30/25 - 6.21 03/31/25 - 6.03 Current Ratio 09/30/25 - 1.89 06/30/25 - 1.79 03/31/25 - 1.83 Quick Ratio 09/30/25 - 1.30 06/30/25 - 1.22 03/31/25 - 1.26 Operating Margin 09/30/25 - 12.75 06/30/25 - 12.55 03/31/25 - 12.19 Net Margin 09/30/25 - 11.99 06/30/25 - 11.73 03/31/25 - 11.14 Pre-Tax Margin 09/30/25 - 16.07 06/30/25 - 15.70 03/31/25 - 15.12 Book Value 09/30/25 - 5.55 06/30/25 - 5.24 03/31/25 - 4.93 Inventory Turnover 09/30/25 - 3.15 06/30/25 - 3.08 03/31/25 - 2.96 Debt-to-Equity 09/30/25 - 0.26 06/30/25 - 0.25 03/31/25 - 0.22 Debt-to-Capital 09/30/25 - 20.39 06/30/25 - 19.69 03/31/25 - 18.13

Powered by Zacks Investment Research ©